181 related articles for article (PubMed ID: 33795838)
1. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H
Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838
[TBL] [Abstract][Full Text] [Related]
2. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
[TBL] [Abstract][Full Text] [Related]
3. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C
J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220
[TBL] [Abstract][Full Text] [Related]
6. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
[TBL] [Abstract][Full Text] [Related]
7. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
8. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.
Liang R; Rimmelé P; Bigarella CL; Yalcin S; Ghaffari S
Cell Cycle; 2016; 15(6):861-7. PubMed ID: 26929388
[TBL] [Abstract][Full Text] [Related]
9. LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway.
Nie Z; Shi L; Song K; Xu X; Ding P; Lu B; Wu G; Ma X
Cell Signal; 2022 Jul; 95():110357. PubMed ID: 35589047
[TBL] [Abstract][Full Text] [Related]
10. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells.
Qi W; Weber CR; Wasland K; Roy H; Wali R; Joshi S; Savkovic SD
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G264-72. PubMed ID: 21109589
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand.
Engström M; Karlsson R; Jönsson JI
Exp Hematol; 2003 Apr; 31(4):316-23. PubMed ID: 12691919
[TBL] [Abstract][Full Text] [Related]
13. FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.
Lin A; Piao HL; Zhuang L; Sarbassov dos D; Ma L; Gan B
Cancer Res; 2014 Mar; 74(6):1682-93. PubMed ID: 24448243
[TBL] [Abstract][Full Text] [Related]
14. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.
Stahl M; Dijkers PF; Kops GJ; Lens SM; Coffer PJ; Burgering BM; Medema RH
J Immunol; 2002 May; 168(10):5024-31. PubMed ID: 11994454
[TBL] [Abstract][Full Text] [Related]
15. Screening Health-Promoting Compounds for Their Capacity to Induce the Activity of FOXO3.
Jimenez L; Silva A; Calissi G; Grenho I; Monteiro R; Mayoral-Varo V; Blanco-Aparicio C; Pastor J; Bustos V; Bracher F; Megías D; Ferreira BI; Link W
J Gerontol A Biol Sci Med Sci; 2022 Aug; 77(8):1485-1493. PubMed ID: 34508571
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.
Lu H; Zhang C; Song N; Lu C; Tong L; Huang X; Kim YC; Chen J; Xu W
Cell Physiol Biochem; 2017; 43(1):158-171. PubMed ID: 28848093
[TBL] [Abstract][Full Text] [Related]
18. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.
Ye Y; Ge YM; Xiao MM; Guo LM; Li Q; Hao JQ; Da J; Hu WL; Zhang XD; Xu J; Zhang LJ
J Gastroenterol; 2016 Mar; 51(3):230-40. PubMed ID: 26201869
[TBL] [Abstract][Full Text] [Related]
19. FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway.
Zhou J; Liao W; Yang J; Ma K; Li X; Wang Y; Wang D; Wang L; Zhang Y; Yin Y; Zhao Y; Zhu WG
Autophagy; 2012 Dec; 8(12):1712-23. PubMed ID: 22931788
[TBL] [Abstract][Full Text] [Related]
20. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia.
Lee JW; Nam H; Kim LE; Jeon Y; Min H; Ha S; Lee Y; Kim SY; Lee SJ; Kim EK; Yu SW
Autophagy; 2019 May; 15(5):753-770. PubMed ID: 30523761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
